Status:
COMPLETED
Aerobic Exercise for the Improvement of Cognition and Enhancement of Recovery in Post-acute Schizophrenia
Lead Sponsor:
Ludwig-Maximilians - University of Munich
Collaborating Sponsors:
RWTH Aachen University
Charite University, Berlin, Germany
Conditions:
Schizophrenia
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The study investigates the efficacy of aerobic exercise on cognitive performance and brain plasticity in schizophrenia.
Detailed Description
This multi-center, two-arm, parallel-group, randomized placebo-controlled add-on clinical trial investigates the efficacy of aerobic exercise on cognitive performance and brain plasticity in schizophr...
Eligibility Criteria
Inclusion
- Informed consent given by the subject; DSM-IV-TR diagnosis of schizophrenic psychosis (295.10-30, 295.90); age 18 to 65 years, male or female; PANSS at baseline: total score ≤ 75, proper contraception in female patients of childbearing potential; treatment with one or two antipsychotics in a stable dose of at least two weeks, body mass index between 18 and 40.
Exclusion
- Lack of accountability; positive urine drug-screening for illicit drugs at screening (except benzodiazepines); serious suicidal risk at screening visit; other relevant interferences of axis 1 according to diagnostic evaluation (MINI); other relevant neurological or other medical disorders; pregnancy or lactation.
Key Trial Info
Start Date :
June 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT03466112
Start Date
June 1 2016
End Date
December 1 2021
Last Update
March 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ludwig-Maximilians-University of Munich
Munich, Bavaria, Germany, 80366